Eyenovia, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
    • Specialty Pharmaceuticals
  • Biotechnology
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • PGP Holdings V
See more in Biomedtracker

Latest on Eyenovia, Inc.

Scrip

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C

Scrip

Deal Watch: BI Acquires Nerio For Novel Immune Checkpoint Inhibitor

 
• By Joseph Haas and Mary Jo Laffler

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim Acquires Nerio The

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip

Asia Deal Watch: Takeda To Team Up With Protagonist On Treatment For Polycythemia Vera

 
• By Joseph Haas, Anju Ghangurde, Lisa Takagi, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Takeda, Protagonist Partner On Pha